Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure, page-47

  1. 274 Posts.
    lightbulb Created with Sketch.  66
    No .
    From the clinical trial info site about the Phase 3 Crohn's Disease trial;
    https://clinicaltrials.gov/ct2/show/NCT00482092

    Column 1 Column 2
    0 Estimated Primary Completion Date : July 2018
    1 Estimated Study Completion Date : July 2020

    Some time during July 2018 it is thought the final Primary measure will be taken from the last person enrolled in the trial which is, are they in remission i.e. are they cured of Crohn's Disease at least for the time being as per the Primary outcome measure. We should be told the outcome of the Primary and Secondary measures in a month or two after July 2018.

    The Phase 3 trial does not finish until around July 2020, my guess is to see how long the treatment lasts for. Do the effects last for at least 2 years, or less, will any re-treatment be necessary.

    So we wait, unless the FDA changes the rules about how much needs to be known over the following years before release could be considered.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
$2.06
Change
0.020(0.98%)
Mkt cap ! $2.652B
Open High Low Volume
$2.11 $2.12 $2.05 2.014M

Buyers (Bids)

Vol. Price($)
65890 $2.05
 

Sellers (Offers)

Price($) Vol.
$2.07 19861
Last trade - 16.25pm 31/07/2026 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.